Laura K. Shawver
- Molecular Biology top 2%
- Oncology top 1%
- Cancer Research top 1%
- Radiology, Nuclear Medicine and Imaging top 2%
- Pulmonary and Respiratory Medicine top 5%
- Co-authors
- Axel UllrichKarl H. PlateB MillauerDennis J. SlamonGerald McMahonLaurie M. StrawnCho TangLi Sun
- Topics
- Angiogenesis and VEGF in Cancer (12 papers)Cancer, Hypoxia, and Metabolism (11 papers)HER2/EGFR in Cancer Research (7 papers)
- Partner nations
- United StatesGermanyJapan
In The Last Decade
Laura K. Shawver
46 papers receiving 4.9k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Molecular Biology 3.4k
- Oncology 2.0k
- Cancer Research 1.2k
- Radiology, Nuclear Medicine and Imaging 581
- Pulmonary and Respiratory Medicine 562
Countries citing papers authored by Laura K. Shawver
This map shows the geographic impact of Laura K. Shawver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura K. Shawver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura K. Shawver more than expected).
Fields of papers citing papers by Laura K. Shawver
This network shows the impact of papers produced by Laura K. Shawver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura K. Shawver. The network helps show where Laura K. Shawver may publish in the future.
Co-authorship network of co-authors of Laura K. Shawver
This figure shows the co-authorship network connecting the top 25 collaborators of Laura K. Shawver. A scholar is included among the top collaborators of Laura K. Shawver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura K. Shawver. Laura K. Shawver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 84 | |
| 3 | 63 | |
| 4 | 72 | |
| 5 | 8 | |
| 6 | 409 | |
| 7 | 112 | |
| 8 | 158 | |
| 9 | 18 | |
| 10 | 57 | |
| 11 | 130 | |
| 12 | 2 | |
| 13 | 5 | |
| 14 | Ligand-like effects induced by anti-c-erbB-2 antibodies do not correlate with and are not required for growth inhibition of human carcinoma cells. | 28 |
| 15 | Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutantbreakdown → | 1036 |
| 16 | p185c-erbB-2 signal enhances cisplatin-induced cytotoxicity in human breast carcinoma cells: association between an oncogenic receptor tyrosine kinase and drug-induced DNA repair. | 113 |
| 17 | A monoclonal antibody against the c-erbB-2 protein enhances the cytotoxicity of cis-diamminedichloroplatinum against human breast and ovarian tumor cell lines. | 200 |
| 18 | 1 | |
| 19 | 19 | |
| 20 | Immunoquantitation of cytochrome b5 and methylcholanthrene-induced cytochromes P-450. | 2 |
About Laura K. Shawver
Laura K. Shawver is a scholar working on Oncology, Cancer Research and Pharmacology, having authored 47 papers that have together received 5.1k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (12 papers), Cancer, Hypoxia, and Metabolism (11 papers) and HER2/EGFR in Cancer Research (7 papers). The work is most often cited by research in Cancer Research (1.2k citations), Oncology (2.0k citations) and Molecular Biology (3.4k citations). Laura K. Shawver has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Axel Ullrich, Karl H. Plate, B Millauer, Axel Ullrich, Dennis J. Slamon, Gerald McMahon, Laurie M. Strawn, Cho Tang, Li Sun and T. Annie T. Fong. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.